Drugs Made In America Acquisition (DMAA) Technical Analysis
As of 2026-10-26, DMAA last traded at 10.88 USD (+0.05% on the day) and is in a range on the daily timeframe — insufficient history for 200-DMA. Nearest levels: 10.83 USD support below, no clear near resistance above. 14-day RSI is 45.5 (neutral).
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
Is DMAA in an uptrend or downtrend?
Drugs Made In America Acquisition is in a range — insufficient history for 200-DMA.
| Last close | 10.88 USD (+0.05%) |
|---|---|
| 20-day average | 10.871 USD |
| 50-day average | 10.818 USD |
| 200-day average | n/a |
Key support and resistance levels for DMAA
Derived from swing pivots over the last 69 sessions:
No clearly-defined swing levels in the current range.
| Level | Type | Strength | Touches |
|---|---|---|---|
| 10.83 USD | Support | Strong | 3 |
| 10.653 USD | Support | Strong | 3 |
DMAA 52-week range, momentum and volatility
| 52-week high | 10.89 USD (0.1% below) |
|---|---|
| 52-week low | 10.61 USD (2.5% above) |
| 14-day RSI | 45.5 (Neutral) |
| 14-day ATR | 0.015 USD (0.14% of price, Low volatility) |
Related research pages
More on DMAA
Frequently asked questions
Is Drugs Made In America Acquisition (DMAA) in an uptrend or downtrend?
As of 2026-10-26, DMAA is in a range on the daily timeframe — insufficient history for 200-DMA. Last close 10.88 USD vs 50-day average 10.818 USD and 200-day average n/a.
What are the key support and resistance levels for DMAA?
Nearest support is around 10.83 USD (strong, 3 touches). No clear resistance above price in range. Levels are derived from swing pivots over the last ~200 sessions.
What is DMAA's 52-week high and low?
Over the last 52 weeks, DMAA traded between 10.61 USD and 10.89 USD. It is currently 0.1% below its 52-week high.
Is DMAA overbought or oversold?
The 14-day RSI is 45.5 — in a neutral 30–70 range. Momentum reads as neutral.
How volatile is DMAA?
Its 14-day Average True Range is 0.015 (0.14% of price) — low volatility relative to price.